Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Treating Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF2) Trial

NCT00340314 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT00340314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00340314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Treating Paroxysmal Atrial Fibrillation. The Ablation for Paroxysmal Atrial Fibrillation (APAF2) Trial
Lead sponsor
IRCCS San Raffaele
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
May 31, 2006
Enrollment
198
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation